Drugs Made In America Acquisition (DMII) Other Non-Current Assets (2024)
Drugs Made In America Acquisition (DMII) reported Other Non-Current Assets of $78449.0 for Q4 2024.
Drugs Made In America Acquisition (DMII) has 1 years of Other Non-Current Assets data on file, last reported at $78449.0 in Q4 2024.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $78449.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $78449.0 (changed N/A YoY) and the FY2024 annual result came in at $78449.0, changed N/A from the prior year.
- Other Non-Current Assets was little changed at $78449.0 in Q4 2024 per DMII's latest filing.
- Across five years, Other Non-Current Assets topped out at $78449.0 in Q4 2024 and bottomed at $78449.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 447,113.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 9,359.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 10,807.00 |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 78,449.00 |